Reva Medical (ASX:RVA) said this week that it inked four new distribution agreements, bringing its commercial operations to seven European countries.
The San Diego, Calif.-based company said the deals serve to expand the reach of its drug-eluting bioresorbable scaffold, Fantom Encore.
Get the full story at our sister site, Drug Delivery Business News.
The post Reva brings bioresorbable scaffolds to new markets appeared first on MassDevice.